The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial
Status:
Unknown status
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
A short term post-market monitoring of serum prolactin level change among patients with
schizophrenia shifting from other antispychotics to different dosages of aripiprazole.